Next Article in Journal
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
Previous Article in Journal
Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant with Inactivated Newcastle Disease Virus Vaccine in Chickens
 
 
Article

Article Versions Notes

Vaccines 2022, 10(6), 896; https://doi.org/10.3390/vaccines10060896
Action Date Notes Link
article xml file uploaded 3 June 2022 12:36 CEST Original file -
article xml uploaded. 3 June 2022 12:36 CEST Update -
article pdf uploaded. 3 June 2022 12:36 CEST Version of Record https://www.mdpi.com/2076-393X/10/6/896/pdf-vor
article html file updated 3 June 2022 12:38 CEST Original file -
article xml file uploaded 3 June 2022 12:53 CEST Update -
article xml uploaded. 3 June 2022 12:53 CEST Update -
article pdf uploaded. 3 June 2022 12:53 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/896/pdf-vor
article html file updated 3 June 2022 12:55 CEST Update -
article xml file uploaded 7 June 2022 02:44 CEST Update -
article xml uploaded. 7 June 2022 02:44 CEST Update https://www.mdpi.com/2076-393X/10/6/896/xml
article pdf uploaded. 7 June 2022 02:44 CEST Updated version of record https://www.mdpi.com/2076-393X/10/6/896/pdf
article supplementary file uploaded. 7 June 2022 02:44 CEST - https://www.mdpi.com/2076-393X/10/6/896#supplementary
article html file updated 7 June 2022 02:46 CEST Update -
article html file updated 3 August 2022 03:25 CEST Update https://www.mdpi.com/2076-393X/10/6/896/html
Back to TopTop